KP Tissue Inc. KPTSF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- |
| Operating Income | -- | -- | -- | -- | -- |
| Income Before Tax | 96.99% | 187.71% | 226.13% | -41.59% | -30.12% |
| Income Tax Expenses | -- | -- | -- | -74.68% | -74.68% |
| Earnings from Continuing Operations | 99.46% | 192.92% | 233.26% | -40.48% | -28.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.46% | 192.92% | 233.26% | -40.48% | -28.54% |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 99.00% | 192.13% | 232.01% | -40.69% | -28.75% |
| Normalized Basic EPS | 109.20% | 223.35% | 307.22% | -41.73% | -26.45% |
| EPS Diluted | 99.00% | 192.13% | 232.01% | -40.69% | -28.75% |
| Normalized Diluted EPS | 109.20% | 223.35% | 307.22% | -41.73% | -26.45% |
| Average Basic Shares Outstanding | 0.28% | 0.28% | 0.27% | 0.26% | 0.24% |
| Average Diluted Shares Outstanding | 0.28% | 0.28% | 0.27% | 0.26% | 0.24% |
| Dividend Per Share | 0.95% | 0.70% | -1.96% | -2.74% | -2.90% |
| Payout Ratio | -0.50% | -0.66% | -0.71% | 0.63% | 0.36% |